AP NEWS

Cegedim: EBITDA margin improved in the first half of 2018

September 17, 2018

Press Release -------------

First-half financial information at June 30, 2018 IFRS - Regulated information - Audited

Cegedim: EBITDA margin improved in the first half of 2018

-- Health insurance, HR and e-services division EBITDA rose 33.5% -- EBITDA fell at the Healthcare professionals division -- Outlook confirmed

Disclaimer: This press release is available in French and in English. In the event of any difference between the two versions, the original French version takes precedence. This press release may contain inside information. It was sent to Cegedim’s authorized distributor on September 17, 2018, no earlier than 5:45 pm Paris time. The terms “business model transformation” and “BPO” are defined in the glossary. Owing to the disposal of the Group’s Cegelease and Eurofarmat businesses, announced in 2017 and completed on February 28, 2018, the consolidated 2017 and 2018 financial statements are presented according to IFRS 5, “Non-current assets held for sale and discontinued”. The Group also applies IFRS 15, “Revenue from contracts with customers”. See the annexes for more details.

CONFERNCE CALL AT 6:15 PM (PARIS TIME) ON SEPTEMBER 17 FR: +33 1 72 72 74 03 US: +1 844 286 0643 UK: +44 207 1943 759 PIN Code: 35537485# Webcast at:www.cegedim.fr/webcast ----------------------------------------------------------------------------------

Boulogne-Billancourt, France, September 17, 2018 after the market close

Cegedim, an innovative technology and services company, posted consolidated H1 2018 revenues from continuing activities of €227.6 million, up 1.6% on a reported basis and 1.8% like for like compared with the same period in 2017. First-half EBITDA came to €33.3 million, up 11.8% year on year. EBITDA margin improved from 13.3% a year earlier to 14.6% in H1 2018.

Health insurance, HR and e-services division revenues rose 6.6%, while Healthcare professionals division revenues fell 6.9%. The BPO business delivered a noteworthy performance, boosting sales by 14.0% over the second quarter of 2018 and posting revenues of €17.9 million for the first half, an 11.2% improvement over the same period in 2017. EBITDA rose by 33.5% at the Health insurance, HR and e-services division, but fell 42.4% at the Healthcare professionals division.

In 2018, the Group is fine-tuning the updated business model it first adopted in 2015.

Income statement summary

Consolidated revenues from continuing activities for the first half of 2018 came to €227.6 million, up 1.6% as reported. Excluding a currency headwind of 0.7% and a positive impact from acquisitions of 0.4%, revenues rose 1.8%. In like-for-like terms, revenues rose 6.0% at the Health insurance, HR and e-services division and fell 5.2% at the Healthcare professionals division.

EBITDA rose by €3.5 million, or 11.8%, to €33.3 million. The margin increased from 13.3% in H1 2017 to 14.6%. The main reasons for the EBITDA trend were a decrease in purchases consumed and external expenses, set against an increase in personnel costs.

Depreciation and amortization costs climbed by €1.8 million to €21.4 million, compared with €19.5 million in first half 2017. Amortization of R&D expenses notably increased by €1.0 million over the period.

EBIT before special items increased by €1.7 million, or 16.7%, to €11.9 million. The margin improved to 5.2% in the first half of 2018 compared with 4.6% in H1 2017.

Exceptional items in the first half of 2018 amounted to a €9.6 million charge, against an €11.7 million charge in the year-earlier period. The decline was mainly attributable to a drop in intangible fixed asset amortization linked to assets set to become obsolete, partly offset by an increase in restructuring costs, including €4 million in fees related to the Cegelease divestment.

Net cost of financial debt decreased by €1.2 million, or 35.3%, to €2.2 million in first half 2018 compared with €3.4 million in first half 2017. The decrease reflects the positive impact of refinancing deals struck in the first half of 2017.

Tax amounted to a charge of €0.8 million in H1 2018 compared with a €1.2 million charge in H1 2017, chiefly due to the recognition of deferred tax assets in France.

As a result, consolidated net profit attributable to the Group was a profit of €0.7 million versus a loss of €3.8 million in 2017. Consolidated net profit from continuing activities was a loss of €0.7 million compared with a loss of €6.1 million in the year-earlier period. Earnings per share before special items was a profit of €0.2 per share against a loss of €0.1 in H1 2017. Earnings per share amounted to €0.0 compared with a loss of €0.3 in 2017.

H1 2018 H1 2017 Chg. €m % €m % % ------ ----- ------ ----- ------- Revenues 227.6 100.0 224.1 100.0 +1.6% EBITDA 33.3 14.6 29.8 13.3 +11.8% Depreciation & amortization (21.4) (9.4) (19.5) (8.7) +9.3% EBIT before special items 11.9 5.2 10.2 4.6 +16.7% Special items (9.6) (4.2) (11.7) (5.2) (17.8)% EBIT 2.3 1.0 (1.5) (0.7) n.m. Cost of net financial debt (2.2) (1.0) (3.4) (1.5) (35.2)% Tax expenses (0.8) (0.3) (1.2) (0.5) (36.8)% Consolidated net profit from continuing activities (0.7) (0.3) (6.1) (2.7) (89.2)% Net earnings from activities held for sale 0.0 0.0 2.4 1.1 n.m. Net earnings from activities sold 1.3 0.6 0.0 0.0 - Profit attributable to the owners of the parent 0.7 0.3 (3.8) (1.7) n.m. EPS before special items 0.2 - (0.1) - n.m. EPS 0.0 - (0.3) - n.m. -------------------------------------------------- ------ ----- ------ ----- -------

Analysis of business trends by division

-- Key figures by division

Revenues EBIT before EBITDA special items In € million H1 2018 H1 2017 H1 2018 H1 2017 H1 2018 H1 2017 ----------------------------------- ------- ------- ------- ------- ------- ------- Health insurance, HR and e-services 149.5 140.3 13.4 8.8 24.2 18.1 Healthcare professionals 76.2 81.8 (0.9) 4.6 6.9 12.0 Corporate and others 1.9 2.0 (0.6) (3.2) 2.2 (0.3) Cegedim 227.6 224.1 11.9 10.2 33.3 29.8 ----------------------------------- ------- ------- ------- ------- ------- -------

-- Health insurance, HR and e-services

The division’s H1 2018 revenues came to €149.5 million, up 6.6% as reported. The March 30, 2018, Rue de la Paye acquisition in France boosted revenues by 0.7%. Currency translation had virtually no impact. Like-for-like revenues rose 6.0% over the period.H1 2018 EBITDA rose 33.5%, to €24.2 million, compared with €18.1 million in H1 2017. The EBITDA margin improved to 16.2%, 3.3 percentage points higher than a year ago.

The Health insurance, HR and e-services division represented 65.7% of consolidated revenues from continuing activities, compared with 62.6% over the same period a year earlier.

The businesses that made the biggest contributions to first-half revenue growth were Cegedim SRH (HR management solutions), Cegedim e-business (digitalization and data exchange), sales statistics for pharmaceutical products, and third-party payment flow management in France. The businesses that made the biggest contributions to first-half EBITDA growth were Cegedim SRH, sales statistics for pharmaceutical products, Cegedim e-business, and third-party payment flow management in France.

-- Healthcare professionals

The division’s H1 2018 revenues came to €76.2 million, down 6.9% as reported. Currency translation was a 1.7% headwind. Acquisitions and divestments had virtually no impact. Like-for-like revenues fell 5.2% over the period.H1 2018 EBITDA fell 42.4%, to €6.9 million, compared with €12.0 million in H1 2017. The EBITDA margin contracted to 9.1%, 5.6 percentage points lower than a year ago.

The Healthcare professionals division represented 33.5% of consolidated revenues from continuing activities, compared with 36.5% over the same period a year earlier.

As expected, first-half revenue were hampered by the doctor computerization businesses in the US, the UK and Spain ahead of the release of new versions, whose impact will not be felt until 2019. EBITDA fell mainly because of doctor computerization activities in the US and Spain, and pharmacy computerization in France owing to a demanding comparison.

-- Corporate and others

The division’s H1 2018 revenues came to €1.9 million, down 2.8% as reported and like for like. Currency translation, acquisitions and divestments had no impact.H1 2018 EBITDA rose €2.5 million to €2.2 million, compared with a €0.3 million loss in H1 2017.

The Corporate and others division represented 0.9% of consolidated revenues from continuing activities in H1 2018, the same as in H1 2017.

EBITDA growth is attributable to the performance of Cegedim_IT.

Balance sheet structure

Acquisition goodwill was €173.3 million at June 30, 2018, compared with €167.8 million at end-December 2017. The €5.5 million increase, or 3. 3%, was chiefly attributable to the €6.5 million impact of the Rue de la paye acquisition in France. Acquisition goodwill represented 29.2% of the total balance sheet at June 30, 2018, compared with 22.5% at December 31, 2017.

Cash and equivalents amounted to €13.6 million at June 30, 2018, down €5.1 million compared with December 31, 2017.

Shareholders’ equity rose €2.3 million, or 1.2%, to €195.0 million at June 30, 2018, compared with €197.3 million at December 31, 2017. The increase was primarily due to an additional €8.7 million of Group reserves, which were partly offset by a €0.7 million negative movement in currency translation reserves and the €10.5 million decline in Group net profit. Shareholders’ equity represented 32.9% of the total balance sheet at end-June 2018 compared with 26.4% at end-December 2017.

Net financial debt amounted to €159.7 million, a drop of €76.5 million versus six months ago. This debt represented 81.9% of shareholders’ equity and liabilities at June 30, 2018, down from 119.7% at December 31, 2017.

The Group generated operating free cash flow of €11.4 million compared with €6.1 million at end-2017. The €5.2 million improvement was chiefly attributable to reductions in WCR and in acquisitions of tangible and intangible fixed assets, partly offset by a decline in gross cash flow.

Highlights

-- Bpifrance sells Cegedim shares

Bpifrance Participations sold 1,682,146 Cegedim shares via an accelerated bookbuilding process to French and international institutional investors at a price of €35 per share on February 13, 2018. In the context of the transaction, the shareholders’ agreement dated October 28, 2009, between Mr. Jean-Claude Labrune, FCB (the family holding company controlled by Mr. Labrune), and Bpifrance - as well as the concert between the parties - has been terminated. Following the sale, Cegedim’s free float increased to 44% of capital (vs. 32% before the transaction).

-- Cegelease and Eurofarmat definitively sold

On February 28, 2018, Cegedim announced that it had completed the disposal of Cegelease and Eurofarmat to FRANFINANCE of the Société Générale Group for an amount of €57.5 million plus reimbursement of the shareholder’s loan account, which amounted to €13 million. Of this amount, Cegedim used €30 million to pay down its debt.

The parties have decided that Cegelease and the Cegedim Group will continue to collaborate in France under the current terms as part of a six-year collaboration agreement.

-- Rue de la Paye acquired in France

On March 30, 2018, Cegedim acquired French company Rue de la Paye via its Cegedim SRH subsidiary. The deal will enable the Group to market digital payroll solutions to 2 million SMEs and small businesses in France, including - importantly - thousands of healthcare professionals that are already Cegedim Group clients.

Rue de la Paye’s 2017 revenues were equivalent to around 1% of 2017 consolidated Group revenues, and it earned a profit. It began contributing to the Group’s consolidation scope in April 2018.

-- Tax

On February 21, 2018, Cegedim S.A. received notice that French tax authorities would perform an audit of its accounts covering the period January 1, 2015, to December 31, 2016.

To the best of the company’s knowledge, there were no events or changes after the accounts were closed that would materially alter the Group’s financial situation.

Significant post-closing transactions and events

-- Independent director appointed to Cegedim SA’s board

At the annual general meeting on August 31, 2018, shareholders appointed Ms. Béatrice Saunier to a six-year term as an independent director. Her term will expire following the AGM held to approve the financial statements for the year 2023.

To the best of the company’s knowledge, there were no events or changes after the accounts were closed that would materially alter the Group’s financial situation.

Outlook

-- Cautiously optimistic for 2018

Building on the efforts that it executed with success in 2017, Cegedim continues to pursue its strategy of focusing on organic growth, fueled by a policy of sustained innovation.

For 2018, the Group expects modest like-for-like revenue and EBITDA margin growth. Most of the full-year margin improvement will have taken place in the first half.

The Group does not issue any earnings estimates or forecasts.

-- Potential impact of Brexit

Cegedim deals in local currency in the UK, as it does in every country where it is present. Thus, Brexit is unlikely to have a material impact on the Group’s consolidated EBIT margin before special items.

With regard to healthcare policy, the Group has not identified any major European programs at work in the UK.

The figures cited above include guidance on Cegedim’s future financial performances. This forward-looking information is based on the opinions and assumptions of the Group’s senior management at the time this press release is issued and naturally entails risks and uncertainty. For more information on the risks facing Cegedim, please refer to Chapter 2 points 4.2, “Risk factors and insurance”, and 5.5, “Outlook”, of the 2017 Registration Document filed with the AMF on March 29, 2018, under number D.18-0219.

Financial calendar

September 18, 2018, at 2:30 pm CET SFAF meeting October 25, 2018, after the market close Q3 2018 revenues December 11, 2018, at 2:00 pm CET 9th Investor Summit September 17, 2018, at 6:15 pm CET The Group will hold a conference call hosted by Jan Eryk Umiastowski, Cegedim Chief Investment Officer and Head of Investor Relations. The webcast is available at the following address: www.cegedim.fr/webcast The H1 2018 results presentation is available on the website and on the Group’s financial communications app, Cegedim IR. -------------------------------------------------------------------- France: +33 1 72 72 74 03 Contact numbers: US:+1 844 286 0643 PIN code: 35537485# UK and others: +44 20 71943 759 ---------------- ------------------------------- -------------------

Additional information

The Audit Committee and the Board of Directors met on September 17, 2018, to review the consolidated financial statements for the first half of 2018. The statutory auditors conducted a limited review of the financial statements. The statutory auditors’ report is dated September 17, 2018. Cegedim Group revenues take into account the initial application of IFRS 15 on January 1, 2018. IFRS 15 does not significantly alter the Group’s revenues relative to the principles and methods of revenue recognition used prior to its application. The Group has created systems and tools to identify potentially significant contracts, as well as any changes in the characteristics or volume of business over time that may require additional analysis in respect of IFRS 15.

Annexes

Balance sheet as June 30, 2018

-- Assets as December 31, 2018

In thousands of euros 06.30.2018 12.31.2017 -------------------------------------------------------------------------- ---------- ---------- Goodwill on acquisition 173 293 167 758 Development costs 41 964 22 887 Other intangible fixed assets 109 275 122 962 Intangible fixed assets 151 239 145 849 Property 544 544 Buildings 3 839 4 127 Other tangible fixed assets 29 007 28 057 Construction work in progress 1 444 Tangible fixed assets 33 391 33 172 Equity investments 1 214 913 Loans 12 875 12 986 Other long-term investments 5 455 6 454 Long-term investments - excluding equity shares in equity method companies 19 544 20 353 Equity shares in equity method companies 10 351 10 072 Government - Deferred tax 28 902 27 271 Accounts receivable: Long-term portion 147 210 Other receivables: Long-term portion 0 Financial instruments 629 622 Non-current assets 417 495 405 308 Services in progress 72 78 Goods 3 448 3 567 Advances and deposits received on orders 323 325 Accounts receivables: Short-term portion 109 982 118 170 Other receivables: Short-term portion 38 688 71 220 Cash equivalents 153 8 000 Cash 13 430 10 718 Prepaid expenses 9 921 8 989 Current Assets 176 017 221 068 Asset of activities held for sale - 119 847 Total Assets 593 512 746 223 -------------------------------------------------------------------------- ---------- ----------

-- Liabilities ans shareholders’ equity as of June 30, 20188

In thousands of euros 06.30.2018 12.31.2017 --------------------------------------- ---------- ---------- Share capital 13 337 13 337 Group reserves 186 568 177 881 Group exchange gains/losses -5 663 -5 008 Group earnings 655 11 147 Shareholders’ equity. Group share 194 898 197 357 Minority interests (reserves) 121 -25 Minority interests (earnings) 29 14 Minority interests 150 -11 Shareholders’ equity 195 047 197 346 Long-term financial liabilities 171 059 250 830 Long-term financial instruments 1 025 928 Deferred tax liabilities 7 128 6 362 Non-current provisions 26 208 25 445 Other non-current liabilities 37 56 Non-current liabilities 205 457 283 621 Short-term financial liabilities 2 185 4 040 Short-term financial instruments 1 2 Accounts payable and related accounts 40 872 46 954 Tax and social liabilities 77 756 83 118 Provisions 3 016 3 025 Other current liabilities 69 178 65 098 Current liabilities 193 007 202 236 Liabilities of activities held for sale - 63 020 Total Liabilities 593 512 746 223 --------------------------------------- ---------- ----------

-- Income statements as of June 30, 2018

In thousands of euros 06.30.2018 06.30.2017 ------------------------------------------------------------------- ---------- ---------- Revenue 227 633 224 069 Purchased used -15 365 -16 723 External expenses -58 501 -65 018 Taxes -4 640 -4 030 Payroll costs -114 566 -108 259 Allocations to and reversals of provisions -2 327 -1 329 Change in inventories of products in progress and finished products -6 - Other operating income and expenses -229 -417 Income of equity-accounted affiliates 1 315 1 493 EBITDA 33 316 29 787 Depreciation expenses -21 369 -19 546 Operating income before special items 11 947 10 241 Depreciation of goodwill - - Non-recurrent income and expenses -9 633 -11 719 Other exceptional operating income and expenses -9 633 -11 719 Operating income 2 314 -1 478 Income from cash and cash equivalents 1 077 125 Gross cost of financial debt -4 048 -4 372 Other financial income and expenses 748 811 Cost of net financial debt -2 222 -3 436 Income taxes -1 546 -125 Deferred taxes 793 -1 066 Total taxes -752 -1 191 Share of profit (loss) for the period of equity method companies - -1 Profit (loss) for the period from continuing activities -661 -6 107 Profit (loss) for the period from discontinued activities 1 345 2 358 Consolidated profit (loss) for the period 684 -3 748 Consolidated Net income (loss) attributable to owners of the parent 655 -3 767 Minority interests 29 19 Average number of shares excluding treasury stock 13 941 543 13 975 365 Current Earnings Per Share (in euros) 0,2 -0,1 Earnings Per Share (in euros) 0,0 -0,3 Dilutive instruments Néant Néant ------------------------------------------------------------------- ---------- ---------- Earning for recurring operation per share (in euros) 0,0 -0,3 ------------------------------------------------------------------- ---------- ----------

-- Consolidated cash flow statement as of June 30, 2018

In thousands of euros 06.30.2018 06.30.2017 --------------------------------------------------------------------------------------- ---------- ---------- Consolidated profit (loss) for the period 684 -3 748 Share of earnings from equity method companies -1 315 -1 492 Depreciation and provisions 26 609 33 941 Capital gains or losses on disposals - -266 Cash flow after cost of net financial debt and taxes 25 978 28 435 Cost of net financial debt 2 276 3 267 Tax expenses 39 2 349 Operating cash flow before cost of net financial debt and taxes 28 293 34 051 Tax paid -697 -2 212 Change in working capital requirements for operations: requirement - - Change in working capital requirements for operations: surplus 11 549 3 810 Cash flow generated from operating activities after tax paid and change in working 39 145 35 650 capital requirements (A) Of which net cash flows from operating activities of held for sales -5 145 1 047 Acquisitions of intangible assets -22 208 -23 897 Acquisitions of tangible assets -5 662 -5 849 Acquisitions of long-term investments -2 437 0 Disposals of tangible and intangible assets 88 225 Disposals of long-term investments - 464 Change in loans made and cash advance 106 -9 812 Impact of changes in consolidation scope 64 550 -3 008 Dividends received from outside Group 1 969 0 Net cash flows generated by investment operations (B) 36 405 -41 878 Of which net cash flows connected to investment operations of activities held for sales 13 892 85 Dividends paid to parent company shareholders - - Dividends paid to the minority interests of consolidated companies -55 -13 Capital increase through cash contribution - - Loans issued - 10 500 Loans repaid -82 038 -3 106 Interest paid on loans -1 628 -2 963 Other financial income and expenses paid or received -1 362 -468 Net cash flows generated by financing operations (C) -85 083 3 950 Of which net cash flows related to financing operations of activities held for sales -13 073 132 Change In Cash without impact of change in foreign currency exchange rates (A + B + C) -9 533 -2 279 Impact of changes in foreign currency exchange rates 112 -420 Change in cash -9 421 -2 699 Opening cash 22 998 20 722 Closing cash 13 577 18 024 --------------------------------------------------------------------------------------- ---------- ----------

BPO (Business Process Outsourcing): BPO is the External growth: External growth covers acquisitions contracting of non-core business activities and during the current fiscal year, as well as those which functions to a third-party provider. Cegedim provides have had a partial impact on the previous fiscal year, BPO services for human resources, Revenue Cycle net of sales of entities and/or assets. Management in the US and management services for insurance companies, provident institutions and mutual EBIT: Earnings Before Interest and Taxes. EBIT insurers. corresponds to net revenue minus operating expenses (such as salaries, social charges, materials, energy, Business model transformation: Cegedim decided in fall research, services, external services, advertising, 2015 to switch all of its offerings over to SaaS etc.). It is the operating income for the Cegedim format, to develop a complete BPO offering, and to Group. materially increase its R&D efforts. This is reflected in the Group’s revamped business model. The change has EBIT before special items: This is EBIT restated to altered the Group’s revenue recognition and negatively take account of non-current items, such as losses on affected short-term profitability tangible and intangible assets, restructuring, etc. It corresponds to the operating income from recurring Corporate and others: This division encompasses the operations for the Cegedim Group. activities the Group performs as the parent company of a listed entity, as well as the support it provides to EBITDA: Earnings before interest, taxes, depreciation the three operating divisions. and amortization. EBITDA is the term used when amortization or depreciation and revaluations are not EPS: Earnings Per Share is a specific financial taken into account. “D” stands for depreciation of indicator defined by the Group as the net profit tangible assets (such as buildings, machines or (loss) for the period divided by the weighted average vehicles), while “A” stands for amortization of of the number of shares in circulation. intangible assets (such as patents, licenses and goodwill). EBITDA is restated to take account of Operating expenses: Operating expenses is defined as non-current items, such as losses on tangible and purchases used, external expenses and payroll costs. intangible assets, restructuring, etc. It corresponds to the gross operating earnings from recurring Revenue at constant exchange rate: When changes in operations for the Cegedim Group. revenue at constant exchange rate are referred to, it means that the impact of exchange rate fluctuations Adjusted EBITDA : Consolidated EBITDA adjusted, for has been excluded. The term “at constant exchange 2016, for the €4.0m of negative impact from impairment rate” covers the fluctuation resulting from applying of receivables in the Healthcare Professional division the exchange rates for the preceding period to the current fiscal year, all other factors remaining Net Financial Debt:This represents the Company’s net equal. debt (non-current and current financial debt, bank loans, debt restated at amortized cost and interest on Revenue on a like-for-like basis: The effect of loans) net of cash and cash equivalents and excluding changes in scope is corrected by restating the sales revaluation of debt derivatives. for the previous period as follows: Free cash-flow:Free cash-flow is cash generated, net by removing the portion of sales originating in the of the cash part of the following items: (i) changes entity or the rights acquired for a period identical in working capital requirements, (ii) transactions on to the period during which they were held to the equity (changes in capital, dividends paid and current period; similarly, when an entity is received), (iii) capital expenditure net of transfers, transferred, the sales for the portion in question in (iv) net financial interest paid and (v) taxes paid. the previous period are eliminated. Life-for-like data (L-f-l): At constant scope and exchange rates. EBIT margin: EBIT margin is defined as the ratio of EBIT/revenue. Internal growth: Internal growth covers growth resulting from the development of an existing EBIT margin before special items: EBIT margin before contract, particularly due to an increase in rates special items is defined as the ratio of EBIT before and/or the volumes distributed or processed, new special items/revenue. contracts, acquisitions of assets allocated to a contract or a specific project. Net cash: Net cash is defined as cash and cash equivalent minus overdraft.

Glossaire

About Cegedim: Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs more than 4,200 people in more than 10 countries and generated revenue of €457 million in 2017. Cegedim SA is listed in Paris (EURONEXT: CGM). To learn more, please visit: www.cegedim.com And follow Cegedim on Twitter: @CegedimGroup, LinkedIn and Facebook. . Marina Rosoff Aude Balleydier Jan Eryk Umiastowski For Madis Phileo Cegedim Cegedim Media Relations Chief Investment Officer Follow Cegedim: and Communications Manager and head of Investor Relations Tel.: +33 (0)1 49 09 68 81 Tel.: +33 (0)1 49 09 33 36 Media Relations aude.balleydier@cegedim.com janeryk.umiastowski@cegedim.com Tel: +33 (0)6 71 58 00 34 marina@madisphileo.com

Attachment

-- Cegedim_Results_1S2018_ENG.pdf

AP RADIO
Update hourly